Reductions in 30-day readmission, mortality, and costs with inpatient-to-community pharmacist follow-up.
Wright EA, Graham JH, Maeng D, Tusing L, Zaleski L, Martin R, Seipp R, Citsay B, McDonald B, Bolesta K, Chaundy K, Medico CJ, Gunderman S, Leri F, Guza K, Price R, Gregor C, Parry DT.
Wright EA, et al. Among authors: chaundy k.
J Am Pharm Assoc (2003). 2019 Mar-Apr;59(2):178-186. doi: 10.1016/j.japh.2018.11.005. Epub 2019 Jan 14.
J Am Pharm Assoc (2003). 2019.
PMID: 30655090